Literature DB >> 35485591

Phase 2 Vitamin C Sepsis Trials: Another Brick in the (Evidence) Wall?

Ankita Agarwal1,2, Simon Oczkowski3,4, Jonathan Sevransky1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35485591      PMCID： PMC9118696          DOI： 10.1097/CCM.0000000000005432

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   9.296


× No keyword cloud information.
  5 in total

1.  Who was James Lind, and what exactly did he achieve.

Authors:  Iain Milne
Journal:  J R Soc Med       Date:  2012-12       Impact factor: 5.344

2.  Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.

Authors:  Alpha A Fowler; Jonathon D Truwit; R Duncan Hite; Peter E Morris; Christine DeWilde; Anna Priday; Bernard Fisher; Leroy R Thacker; Ramesh Natarajan; Donald F Brophy; Robin Sculthorpe; Rahul Nanchal; Aamer Syed; Jamie Sturgill; Greg S Martin; Jonathan Sevransky; Markos Kashiouris; Stella Hamman; Katherine F Egan; Andrei Hastings; Wendy Spencer; Shawnda Tench; Omar Mehkri; James Bindas; Abhijit Duggal; Jeanette Graf; Stephanie Zellner; Lynda Yanny; Catherine McPolin; Tonya Hollrith; David Kramer; Charles Ojielo; Tessa Damm; Evan Cassity; Aleksandra Wieliczko; Matthew Halquist
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

3.  Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens.

Authors:  Harm-Jan de Grooth; Wai-Ping Manubulu-Choo; Anthe S Zandvliet; Angélique M E Spoelstra-de Man; Armand R Girbes; Eleonora L Swart; Heleen M Oudemans-van Straaten
Journal:  Chest       Date:  2018-03-06       Impact factor: 9.410

4.  Ascorbic acid dynamics in the seriously ill and injured.

Authors:  C L Long; K I Maull; R S Krishnan; H L Laws; J W Geiger; L Borghesi; W Franks; T C Lawson; H E Sauberlich
Journal:  J Surg Res       Date:  2003-02       Impact factor: 2.192

5.  Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.

Authors:  Alpha A Fowler; Aamer A Syed; Shelley Knowlson; Robin Sculthorpe; Don Farthing; Christine DeWilde; Christine A Farthing; Terri L Larus; Erika Martin; Donald F Brophy; Seema Gupta; Bernard J Fisher; Ramesh Natarajan
Journal:  J Transl Med       Date:  2014-01-31       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.